SCHEMBL21025330

SCHEMBL21025330

CC(C)(C)Cc1ccc2nc[nH]c(=S)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IP6K1 Q92551 5/20 0.40
▸ IP6K3 Q96PC2 1/20 0.40
▸ IP6K2 Q9UHH9 1/20 0.40
▸ PARP1 P09874 6/20 0.36
▸ SLC2A1 P11166 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ QPCT Q16769 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ PPARG P37231 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NCOA2 Q15596 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19286690 0.78 PRKCI (0.53) QPCTPRKCIKDM4EMAPTRAD52
SCHEMBL12726028 0.74 PRKCI (0.41) ESR1QPCTPRKCIKDM4EMAPT
SCHEMBL27828038 0.70 PIM1 (0.64) PARP1CHEK1PIM1AKT1FLT3
SCHEMBL9263181 0.70 PARP1 (0.64) IP6K1IP6K3PARP1CHEK1PIM1
SCHEMBL20193934 0.69 MAP4K4 (0.49) IP6K1
SCHEMBL22042406 0.67 IP6K1 (0.61) IP6K1IP6K3IP6K2PARP1SLC2A1
SCHEMBL21025329 0.67 MAPK1 (0.47) PARP1ESR1PRKCIRAB9AKDM4E
SCHEMBL861279 0.67 KDM4E (0.51) ESR1RAB9AKDM4EMAPT
SCHEMBL9968624 0.66 ESR1 (0.42) ESR1RAB9AKDM4EMAPT
SCHEMBL31013159 0.66 PRKCI (0.54) QPCTPRKCIKDM4EMAPTRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10669252-B2 Benzazepine derivative, preparation method, pharmaceutical composition and use thereof Shanghai De Novo Pharmatech Co., Ltd. (CN) 2020-06-02 — — US disclosed
US-20190152941-A1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai De Novo Pharmatech Co., Ltd. (CN) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10669252-B2 Benzazepine derivative, preparation method, pharmaceutical composition and use thereof TLR8, TLR1, TLR5 IP6K1 2212/4885IP6K3 1672/4885IP6K2 2015/4885
US-20190152941-A1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF TLR8, TLR1, TLR5 IP6K1 2212/4885IP6K3 1672/4885IP6K2 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback